Ullet index:HISAMITSU PHARMACEUTICAL CO.,INC.:4530

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index HISAMITSU PHARMACEUTICAL CO.,INC. Go to web site 4530 Medicals 東証プライム February 1, 2000 1962.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

HISAMITSU PHARMACEUTICAL CO.,INC. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date February 28, 2025 February 29, 2024 February 28, 2023 February 28, 2022 February 28, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 276,824
plusup
264,877
plusup
256,366
plusup
253,168
plusup
252,299
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 21,759
plusup
13,971
plusup
11,743
plusup
9,659
plusup
9,251
plus
Operating Cash Flow(OFC)Help 18,765
plusup
18,187
plusup
12,728
plusdown
19,199
plusup
5,288
plus
Free Cash Flow(FCF)Help 36,328
plusup
15,675
plusup
-11,140
plusdown
6,139
plusdown
13,103
plus
OFC - Net IncomeHelp 58
plusup
56
plusdown
57
plusdown
58
plusdown
60
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 13.41%
plusdown
13.90%
plusup
8.93%
plusdown
12.67%
plusup
3.50%
plus
Current Assets / Amount of SalesHelp 89.69%
plusdown
92.30%
plusdown
111.06%
plusdown
126.11%
plusdown
131.77%
plus
Free Cash Revenue RatioHelp 23.29%
plusup
11.06%
plusup
-8.68%
plusdown
5.11%
plusdown
11.44%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

HISAMITSU PHARMACEUTICAL CO.,INC.

Company where related level is highHelp

Sanko Junyaku Co.,Ltd.
Medrx Co.,Ltd.
Noile-Immune Biotech Inc.
Shionogi & Co.,Ltd.
MORISHITA JINTAN CO.,LTD.
SANTEN PHARMACEUTICAL CO.,LTD.
FunPep Company Limited
HEALIOS K.K.
Astellas Pharma Inc.
SanBio Company Limited